T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Operating Expenses Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual operating expenses in 2023 was 41.49 Million USD , down -32.38% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly operating expenses in 2024 Q1 was 10.45 Million USD , up 25.26% from previous quarter.
  • T2 Biosystems, Inc. reported a annual operating expenses of 56.67 Million USD in annual operating expenses 2022, up 12.61% from previous year.
  • T2 Biosystems, Inc. reported a annual operating expenses of 50.32 Million USD in annual operating expenses 2021, up 31.73% from previous year.
  • T2 Biosystems, Inc. reported a quarterly operating expenses of 8.83 Million USD for 2024 Q2, down -15.54% from previous quarter.
  • T2 Biosystems, Inc. reported a quarterly operating expenses of 11.77 Million USD for 2023 Q1, up 1.91% from previous quarter.

Annual Operating Expenses Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Operating Expenses of T2 Biosystems, Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 41.49 Million USD -32.38%
2022 56.67 Million USD 12.61%
2021 50.32 Million USD 31.73%
2020 38.2 Million USD -12.43%
2019 43.63 Million USD 8.57%
2018 40.18 Million USD -13.56%
2017 46.49 Million USD -3.32%
2016 48.08 Million USD 8.17%
2015 44.45 Million USD 44.34%
2014 30.8 Million USD 54.32%
2013 19.95 Million USD 36.03%
2012 14.67 Million USD 0.0%

Peer Operating Expenses Comparison of T2 Biosystems, Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 72.15%
Prenetics Global Limited 60.73 Million USD 31.682%
Star Equity Holdings, Inc. 16.27 Million USD -155.002%
CareDx, Inc 277.76 Million USD 85.062%
Exact Sciences Corporation 2.06 Billion USD 97.986%
Exagen Inc. 52.29 Million USD 20.651%
Inotiv, Inc. 246.9 Million USD 83.194%
Guardant Health, Inc. 901.62 Million USD 95.398%
Biodesix, Inc. 77.41 Million USD 46.403%
BioNexus Gene Lab Corp. 3.92 Million USD -957.688%
Precipio, Inc. 13.63 Million USD -204.253%
iSpecimen Inc. 16.27 Million USD -154.92%
Natera, Inc. 938.98 Million USD 95.581%
Aspira Women's Health Inc. 24.11 Million USD -72.074%
Standard BioTools Inc. 113.48 Million USD 63.438%
23andMe Holding Co. 420.73 Million USD 90.138%
Castle Biosciences, Inc. 242.78 Million USD 82.909%
Personalis, Inc. 128.14 Million USD 67.619%
Aclaris Therapeutics, Inc. 110.52 Million USD 62.457%
Applied DNA Sciences, Inc. 16.48 Million USD -151.681%
OpGen, Inc. 30.65 Million USD -35.345%
Myriad Genetics, Inc. 600.1 Million USD 93.085%
ICON Public Limited Company 755.64 Million USD 94.509%
NeoGenomics, Inc. 341.25 Million USD 87.841%
Star Equity Holdings, Inc. 16.27 Million USD -155.002%
IDEXX Laboratories, Inc. 1.09 Billion USD 96.203%
RadNet, Inc. 268.87 Million USD 84.568%
MDxHealth SA 71.25 Million USD 41.768%
Psychemedics Corporation 11.33 Million USD -266.102%
Illumina, Inc. 3.81 Billion USD 98.912%
Check-Cap Ltd. 19.28 Million USD -115.14%
Twist Bioscience Corporation 354.18 Million USD 88.284%
DarioHealth Corp. 62.17 Million USD 33.26%
Fulgent Genetics, Inc. 171.9 Million USD 75.862%
Sera Prognostics, Inc. 39.91 Million USD -3.951%
ENDRA Life Sciences Inc. 10.52 Million USD -294.402%
OPKO Health, Inc. 574.68 Million USD 92.78%
Medpace Holdings, Inc. 187.68 Million USD 77.891%
Neogen Corporation 405.23 Million USD 89.761%
Intelligent Bio Solutions Inc. 11.7 Million USD -254.383%
Prenetics Global Limited 60.73 Million USD 31.682%
Mainz Biomed B.V. 27.15 Million USD -52.808%
bioAffinity Technologies, Inc. 8.76 Million USD -373.414%
Trinity Biotech plc 46.49 Million USD 10.756%
Neuronetics, Inc. 82.25 Million USD 49.557%
Sotera Health Company 300.46 Million USD 86.19%
bioAffinity Technologies, Inc. 8.76 Million USD -373.414%